Posts tagged as:

Trexima

Treximet (formerly Trexima)

by James on 15 May 2008

The drug now known as Treximet has been approved for sale in the USA (on the 15th of April, 2008).  It’s expected to hit the shelved any time now, as a prescription medicine. But what is Treximet (formerly Trexima)?  And is it worth all the hype? Actually, I’ve written about Treximet several times before (here [...]

{ 49 comments }

Trexima (and the problem with a double-drug)

by James on 16 April 2007

You might have heard about Pozen’s migraine product, Trexima, which is currently under review in the USA.  I know I’ve heard about it – a lot about it.  I’ve written about Trexima before, more than once. Trexima is a combination drug.  Its key ingredients are sumatriptan succinate (otherwise known as Imitrex) and naproxen sodium.  Both [...]

{ 0 comments }

Trexima – sooner rather than later?

by James on 1 August 2006

There is a lot of hope that the drug Trexima will provide a treatment that is unique to everything else on the market.  In spite of the fact that it is really a combination of drugs already available, it looks like the combination and delivery that Trexima has makes it greater than the sum of [...]

{ 0 comments }

Trexima in the quagmire

by James on 10 June 2006

Yes, the new drug Trexima was supposed to be out sometime soon.  But the FDA (in the USA) wants more information about just how safe the drug is, and that could mean more studies and trials and tests.  If that’s really the case, we might not see it for months – even years. Pozan, the [...]

{ 0 comments }

Trexima – new drug coming soon

by James on 11 February 2006

There’s a new migraine drug that will probably appear on the market in the next few months, currently called Trexima.  In October, the FDA accepted the drug from GlaxoSmithKline and POZEN Inc. for review. Strictly speaking, it’s not 100% new – it’s actually a combination of two drugs that are already on the market.  The [...]

{ 0 comments }